Enhanced Recovery After Spine Surgery
| Status: | Recruiting |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 4/17/2018 |
| Start Date: | November 28, 2016 |
| End Date: | February 2019 |
| Contact: | Ellen M Soffin, MD, PhD |
| Email: | SoffinE@HSS.edu |
| Phone: | (212) 606-1036 |
Enhanced Recovery After Spine Surgery: A Prospective Randomized Controlled Trial to Assess Quality of Recovery and the Biochemical Stress Response to Lumbar Fusion
Enhanced recovery after surgery (ERAS) pathways have been shown to decrease length of stay
and perioperative complications in a range of surgical specialties. To date, ERAS has not
been studied in patients presenting for spine surgery. The investigators have recently
developed an interdisciplinary pathway for spine surgery patients based on the latest
available evidence and guidelines. The aim of this trial is to compare the investigators ERAS
pathway with conventional perioperative management in patients undergoing 1-2 level posterior
lumbar fusion.
and perioperative complications in a range of surgical specialties. To date, ERAS has not
been studied in patients presenting for spine surgery. The investigators have recently
developed an interdisciplinary pathway for spine surgery patients based on the latest
available evidence and guidelines. The aim of this trial is to compare the investigators ERAS
pathway with conventional perioperative management in patients undergoing 1-2 level posterior
lumbar fusion.
Inclusion Criteria:
- Any patient presenting for 1 or 2 level posterior lumbar fusion.
Exclusion Criteria:
- Cognitive impairment (baseline dementia, cognitive dysfunction or inability to consent
to participate).
- Kidney disease: GFR <60 mL/min/1.73 m2 for 3 months or more, irrespective of cause
(Levey et al., 2012).
- Liver disease: transaminitis, cirrhosis, hepatitis, hypoalbuminemia, coagulopathy.
- Pre-existing bowel disease (inflammatory bowel disease, colectomy/
colostomy/diverticular disease).
- Allergy/intolerance/contraindication to any medication or component included in the
ERAS pathway protocol.
- Planned minimally invasive surgical technique including use of the Coflex device.
- Patients whose primary or preferred language is not English.
We found this trial at
1
site
535 E 70th St
New York, New York 10021
New York, New York 10021
(212) 606-1000
Phone: 212-606-1036
Hospital for Special Surgery Founded in 1863, Hospital for Special Surgery is the nation
Click here to add this to my saved trials
